| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |